Stem Cells : An Alternative Therapy for COVID-19 and Cytokine Storm
Front Cover -- Stem Cells -- Copyright Page -- Dedication -- Contents -- List of contributors -- Preface -- Introduction -- 1 Outbreak of novel disease -- 1 Targets of SARS-CoV-2: therapeutic implications for COVID-19 -- 1.1 Introduction -- 1.2 Human targets and pathogenicity of SARS-CoV and SARS-CoV-2 -- 1.2.1 ACE2 -- 1.2.1.1 Effect of ACE2 on various diseases -- 1.2.2 TMPRSS2 -- 1.2.3 Dipeptidyl peptidase 4 (DPP4) -- 1.3 Treatment of COVID-19 -- 1.3.1 Immunological role against SARS-CoV-2 and SARS-CoV -- 1.3.2 Suppression of the HCoV-229E virus by interferon (IFN) -- 1.3.3 Cold plasma treatment -- 1.3.4 Convalescent plasma therapy -- 1.3.5 Immune-modulating treatment -- 1.3.6 Low-dose radiation therapy -- 1.3.7 Mesenchymal stem cells in COVID-19 treatment -- 1.3.8 Potential vaccines -- 1.3.9 Monoclonal antibodies -- 1.3.10 Other treatments -- 1.4 Conclusion and future perspectives -- References -- 2 COVID-19 biology -- 2 COVID-19 biology: cytokine storms and their implications -- 2.1 Introduction -- 2.2 Cytokines and cytokine storm -- 2.3 COVID-19 disease and immunopathogenesis -- 2.4 Cytokine storms in COVID-19 -- 2.4.1 ILs -- 2.4.2 Interferons -- 2.4.3 Tumor necrosis factor-α -- 2.4.4 Colony-stimulating factors -- 2.4.5 Chemokines -- 2.5 Conclusion -- References -- 3 SARS-CoV-2 associated complications -- 3 Comparative clinical investigation of blood profiling in COVID-19 patients -- 3.1 Introduction -- 3.2 Comparative analysis of different physiological parameters in SARS-CoV-2 infection -- 3.2.1 Increase in neutrophils and loss of lymphocytes -- 3.2.2 Decrease in CD4/CD8-type regulatory lymphocyte cells -- 3.2.3 Increase in interleukin-6 and proinflammatory mediators -- 3.2.4 Increase in serum LDH, ALT, AST, CRP, D-dimer, hs-cTnI, ferritin, and other tissue-specific biomarkers..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2023 ©2023 |
|---|---|
| Erschienen: |
San Diego: Elsevier Science & Technology ; 2023 ©2023 |
| Ausgabe: |
1st ed. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Verma, Yogesh Kumar [VerfasserIn] |
|---|
| Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Anmerkungen: |
Description based on publisher supplied metadata and other sources |
|---|
| Umfang: |
1 online resource (437 pages) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1872365434 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1872365434 | ||
| 003 | DE-627 | ||
| 005 | 20240228195652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231208s2023 xx |||||o 00| ||eng c | ||
| 020 | |a 9780323955461 |9 978-0-323-95546-1 | ||
| 035 | |a (DE-627)1872365434 | ||
| 035 | |a (DE-599)KEP099219735 | ||
| 035 | |a (EBC)EBC30979612 | ||
| 035 | |a (EBL)EBL30979612 | ||
| 035 | |a (EBP)099219735 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | |a 616.02774 | |
| 100 | 1 | |a Verma, Yogesh Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stem Cells |b An Alternative Therapy for COVID-19 and Cytokine Storm |
| 250 | |a 1st ed. | ||
| 264 | 1 | |a San Diego |b Elsevier Science & Technology |c 2023 | |
| 264 | 4 | |c ©2023 | |
| 300 | |a 1 online resource (437 pages) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 520 | |a Front Cover -- Stem Cells -- Copyright Page -- Dedication -- Contents -- List of contributors -- Preface -- Introduction -- 1 Outbreak of novel disease -- 1 Targets of SARS-CoV-2: therapeutic implications for COVID-19 -- 1.1 Introduction -- 1.2 Human targets and pathogenicity of SARS-CoV and SARS-CoV-2 -- 1.2.1 ACE2 -- 1.2.1.1 Effect of ACE2 on various diseases -- 1.2.2 TMPRSS2 -- 1.2.3 Dipeptidyl peptidase 4 (DPP4) -- 1.3 Treatment of COVID-19 -- 1.3.1 Immunological role against SARS-CoV-2 and SARS-CoV -- 1.3.2 Suppression of the HCoV-229E virus by interferon (IFN) -- 1.3.3 Cold plasma treatment -- 1.3.4 Convalescent plasma therapy -- 1.3.5 Immune-modulating treatment -- 1.3.6 Low-dose radiation therapy -- 1.3.7 Mesenchymal stem cells in COVID-19 treatment -- 1.3.8 Potential vaccines -- 1.3.9 Monoclonal antibodies -- 1.3.10 Other treatments -- 1.4 Conclusion and future perspectives -- References -- 2 COVID-19 biology -- 2 COVID-19 biology: cytokine storms and their implications -- 2.1 Introduction -- 2.2 Cytokines and cytokine storm -- 2.3 COVID-19 disease and immunopathogenesis -- 2.4 Cytokine storms in COVID-19 -- 2.4.1 ILs -- 2.4.2 Interferons -- 2.4.3 Tumor necrosis factor-α -- 2.4.4 Colony-stimulating factors -- 2.4.5 Chemokines -- 2.5 Conclusion -- References -- 3 SARS-CoV-2 associated complications -- 3 Comparative clinical investigation of blood profiling in COVID-19 patients -- 3.1 Introduction -- 3.2 Comparative analysis of different physiological parameters in SARS-CoV-2 infection -- 3.2.1 Increase in neutrophils and loss of lymphocytes -- 3.2.2 Decrease in CD4/CD8-type regulatory lymphocyte cells -- 3.2.3 Increase in interleukin-6 and proinflammatory mediators -- 3.2.4 Increase in serum LDH, ALT, AST, CRP, D-dimer, hs-cTnI, ferritin, and other tissue-specific biomarkers. | ||
| 700 | 1 | |a Satija, Neeraj Kumar |e mitwirkender |4 ctb | |
| 700 | 1 | |a Raghav, Pawan Kumar |e mitwirkender |4 ctb | |
| 700 | 1 | |a Tyagi, Nishant |e mitwirkender |4 ctb | |
| 700 | 1 | |a Kumar, Subodh |e mitwirkender |4 ctb | |
| 776 | 1 | |z 9780323955454 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780323955454 |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=30979612 |m X:EBC |x Aggregator |z lizenzpflichtig |
| 856 | 4 | 2 | |u http://www.gbv.de/dms/bowker/toc/9780323955454.pdf |m DE-601 |q pdf/application |v 2024-02-28 |x Aggregator |3 Inhaltsverzeichnis |
| 912 | |a ZDB-30-PQE | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a ISIL_DE-Brg3 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_736 | ||
| 912 | |a GBV_ILN_2021 | ||
| 912 | |a ISIL_DE-289 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.02774 | ||
| 980 | |2 206 |1 01 |x 3350 |b 4444634219 |c 00 |f --%%-- |d Online-Ressource |e --%%-- |j --%%-- |h OLR-EBL |k If you are a ThHF affiliate and the E-Book is not fully accessible, please send us a purchase or short time loan request. All others: Inter-library loans and guest access on campus premises is not possible. |y zh |z 24-12-23 | ||
| 980 | |2 736 |1 01 |x 4736 |b 4435705222 |h EBC-Content |y zeg |z 13-12-23 | ||
| 980 | |2 2021 |1 01 |x DE-289 |b 4452924549 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 10-01-24 | ||
| 981 | |2 206 |1 01 |x 3350 |y Full Text only for ThHf affiliates |r https://thh-friedensau.idm.oclc.org/login?url=http://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=30979612 | ||
| 981 | |2 736 |1 01 |x 4736 |r https://ebookcentral.proquest.com/lib/staat/detail.action?docID=30979612 | ||
| 981 | |2 2021 |1 01 |x DE-289 |r https://ebookcentral.proquest.com/lib/kiz-uniulm/detail.action?docID=30979612 | ||
| 995 | |2 206 |1 01 |x 3350 |a OLR-EBL | ||
| 995 | |2 736 |1 01 |x 4736 |a EBC-Content | ||